7:32 am Acceleron Pharma, Celgene (CELG) and collaborators announce two publications in Nature Medicine describing sotatercept and ACE-536 therapeutic potential in beta-thalassemia and myelodysplastic syn
View todays social media effects on XLRN
View the latest stocks trending across Twitter. Click to view dashboard
See who Acceleron is hiring next, click here to view
